Artwork

Content provided by Soundcraft Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Soundcraft Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory

28:39
 
Distribuie
 

Manage episode 447482609 series 3594399
Content provided by Soundcraft Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Soundcraft Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.
But today the science has moved on, to therapy vaccines. Vaccines that take immune cells and "rub their little noses in the antigen" - the substance that forces the body to sit up and take notice of a foreign invader or unusual activity.
Clinical trials abound, by some of the heavy hitters in mRNA and pharmaceuticals, but nothing yet has been commercialised. Wilsons Advisory senior equity analyst Dr Shane Storey reckons we're five years away from a vaccine from the most-likely candidate of mRNA.
In this episode we talk to the coinventor of the first smash hit in cancer vaccines, Gardasil, professor Dr Ian Frazer, and Shane about where the field has come from, and where it's going.

Support the show

Produced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.

  continue reading

Capitole

1. VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory (00:00:00)

2. Professor Dr Ian Frazer (00:02:48)

3. Wilsons Advisory senior equity analyst Dr Shane Storey (00:14:31)

16 episoade

Artwork
iconDistribuie
 
Manage episode 447482609 series 3594399
Content provided by Soundcraft Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Soundcraft Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.
But today the science has moved on, to therapy vaccines. Vaccines that take immune cells and "rub their little noses in the antigen" - the substance that forces the body to sit up and take notice of a foreign invader or unusual activity.
Clinical trials abound, by some of the heavy hitters in mRNA and pharmaceuticals, but nothing yet has been commercialised. Wilsons Advisory senior equity analyst Dr Shane Storey reckons we're five years away from a vaccine from the most-likely candidate of mRNA.
In this episode we talk to the coinventor of the first smash hit in cancer vaccines, Gardasil, professor Dr Ian Frazer, and Shane about where the field has come from, and where it's going.

Support the show

Produced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.

  continue reading

Capitole

1. VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory (00:00:00)

2. Professor Dr Ian Frazer (00:02:48)

3. Wilsons Advisory senior equity analyst Dr Shane Storey (00:14:31)

16 episoade

Όλα τα επεισόδια

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință